Back

Correction to: Anthracycline-induced cardiovascular toxicity: validation of the Heart Failure Association and International Cardio-Oncology Society risk score

European Heart Journal

18 November 2024
Organised by: Logo
Read full article
ESC Journals
You may be interested in
thumbnail
Congress Presentation
Clinical application of the HFA/ICOS score in breast cancer women: its added value in the prediction of chemotherapy-related cardiac dysfunction
26 August 2023
thumbnail
Congress Session
Recent perspectives in cardio-oncology
17 May 2025
thumbnail
Congress Presentation
Assessing the heart failure association international cardio-oncology society risk score for predicting cardiotoxicity in asian breast cancer patients undergoing anthracycline chemotherapy
21 June 2025
thumbnail
ESC Journals
Uprising heart failure therapies for cardio-permissive strategies in cancer therapy-related cardiac dysfunction
1 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources